Stada Arzneimittel (STAGn)

Real-time derived
0.022
0.000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    78.120/88.400
  • Day's Range:
    79.560 - 79.560
  • Type:Equity
  • Market:Germany
  • ISIN:DE0007251803
  • WKN:725180

STAGn Overview

Prev. Close
0.02
Day's Range
79.56-79.56
Revenue
-
Open
83.26
52 wk Range
0-0
EPS
2.58
Volume
0
Market Cap
5.09B
Dividend (Yield)
0.11
(0.13%)
Average Vol. (3m)
49,030
P/E Ratio
31.52
Beta
0.81
1-Year Change
0%
Shares Outstanding
62,258,129
Next Earnings Date
-
What is your sentiment on Stada Arzneimittel?
or
Vote to see community's results!

Stada Arzneimittel Company Profile

Employees
12471
Market
Germany

STADA Arzneimittel Aktiengesellschaft, together with its subsidiaries, engages in the health care and pharmaceuticals business worldwide. The company operates in two segments, Generics and Branded Products. It offers specialty pharmaceuticals, and unbranded and branded generic products; and over the counter, cosmeceuticals, food supplements, and diagnostics products. The company also provides Zoflora, a disinfectant to protect from bacteria; Grippostad, a medicine for flu infection and cold; SNUP spray for decongestion of cold; Aqualor for the self-medication of sinusitis and sore throat; Vitaprost, a medication for prostate cancer; Nizoral/Terzolin, a medical solution for dandruff; Ladival, a solution for sun protection; and Covonia for cough. It serves doctors, pharmacists, patients, health insurance organizations, buying groups, pharmacy chains, and wholesalers or mail-order companies. STADA Arzneimittel Aktiengesellschaft has a licensing agreement with Bausch + Lomb to commercialize Lucentis (ranibizumab) biosimilar candidate, which is under development in the United States and Canada. The company was founded in 1895 and is headquartered in Bad Vilbel, Germany. STADA Arzneimittel Aktiengesellschaft is a subsidiary of Nidda Healthcare GmbH.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyStrong BuyStrong BuyStrong BuyStrong Buy
Technical IndicatorsStrong BuyStrong BuyNeutralBuyBuy
SummaryStrong BuyStrong BuyBuyStrong BuyStrong Buy
    Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
    Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.